UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

Alkene Hydroamination via Earth‐Abundant Transition Metal (Iron, Cobalt, Copper and Zinc) Catalysis: A Mechanistic Overview

Advanced synthesis & catalysis, 2020-04, Vol.362 (8), p.1550-1563

2020

Link zum Volltext

Verfügbarkeit prüfen

Small rings in the bigger picture: ring expansion of three- and four-membered rings to access larger all-carbon cyclic systems

Chemical Society reviews, 2021-07, Vol.5 (13), p.7513-7538

2021

Link zum Volltext

Verfügbarkeit prüfen

Declining Incidence of Catastrophic Cervical Spine Injuries in French Rugby: 1996-2006

The American journal of sports medicine, 2009-02, Vol.37 (2), p.319-323

2009

Link zum Volltext

Verfügbarkeit prüfen

Declining Incidence of Catastrophic Cervical Spine Injuries in French Rugby

The American journal of sports medicine, 2009-02, Vol.37 (2), p.319

2009

Link zum Volltext

Verfügbarkeit prüfen

Reduced Versus Full Doses of Irradiation After 3 Cycles of Combined Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in Early Stage Hodgkin Lymphomas: Results of a Randomized Trial

Cancer, 2010-09, Vol.116 (17), p.4054-4062

2010

Link zum Volltext

Verfügbarkeit prüfen

Early Versus Late Intensification for Patients With High-Risk Hodgkin Lymphoma-3 Cycles of Intensive Chemotherapy Plus Low-Dose Lymph Node Radiation Therapy Versus 4 Cycles of Combined Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Myeloablative Chemotherapy With Autologous Stem Cell Transplantation Five-Year Results of a Randomized Trial on Behalf of the GOELAMS Group

Cancer, 2008-12, Vol.113 (12), p.3323-3330

2008

Link zum Volltext

Verfügbarkeit prüfen

Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas

Cancer, 2010-09, Vol.116 (17), p.4054-4062

2010

Link zum Volltext

Verfügbarkeit prüfen

Author reply

Cancer, 2007-07, Vol.110 (1), p.230-230

2007

Link zum Volltext

Verfügbarkeit prüfen

Author reply

Cancer, 2007-07, Vol.110 (1), p.230-230

2007

Link zum Volltext

Verfügbarkeit prüfen

Predictive and discriminating three‐risk‐group prognostic scoring system for staging Hodgkin lymphomas

Cancer, 2007-01, Vol.109 (2), p.256-264

2007

Link zum Volltext

Verfügbarkeit prüfen

Fifteen‐year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high‐dose irradiation

British journal of haematology, 2002-07, Vol.118 (1), p.189-194

2002

Link zum Volltext

Verfügbarkeit prüfen

Early versus late intensification for patients with high‐risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low‐dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation

Cancer, 2008-12, Vol.113 (12), p.3323-3330

2008

Link zum Volltext

Verfügbarkeit prüfen

Twenty‐year disease and treatment‐associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3‐month anthracycline‐based chemotherapy followed by extended high‐dose radiation

Cancer, 2008-02, Vol.112 (4), p.846-855

2008

Link zum Volltext

Verfügbarkeit prüfen

Fifteen-year secondary leukaemia risk observed in 762 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation

British journal of haematology, 2002-07, Vol.118 (1), p.189

2002

Link zum Volltext

Verfügbarkeit prüfen

Binedaline Binding to Plasma Proteins and Red Blood Cells in Humans

Journal of pharmaceutical sciences, 1985-07, Vol.74 (7), p.727-730

1985

Link zum Volltext

Verfügbarkeit prüfen

Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients

Journal of clinical oncology, 1996-06, Vol.14 (6), p.1928-1935

1996

Link zum Volltext

Verfügbarkeit prüfen

MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians

Journal of clinical oncology, 1999-02, Vol.17 (2), p.730-730a

1999

Link zum Volltext

Verfügbarkeit prüfen

Modelling of the oxidation of Suspended Silicon Nanowires

MRS proceedings, 2008, Vol.1144 (1), Article 1144-LL18-06

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(70)
Life Sciences & Biomedicine
(58)
Humans
(54)
Female
(36)
Adult
(30)
Male
(29)
Middle Aged
(26)
Life Sciences
(25)
Biological And Medical Sciences
(24)
Aged
(22)
Oncology
(20)
Medical Sciences
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Combined Modality Therapy
(15)
Adolescent
(12)
Physical Sciences
(12)
Cancer
(11)
Hodgkin Disease - Drug Therapy
(11)
Hodgkin Disease - Radiotherapy
(11)
Prospective Studies
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alkene Hydroamination via Earth‐Abundant Transition Metal (Iron, Cobalt, Copper and Zinc) Catalysis: A Mechanistic Overview

Small rings in the bigger picture: ring expansion of three- and four-membered rings to access larger all-carbon cyclic systems

Declining Incidence of Catastrophic Cervical Spine Injuries in French Rugby: 1996-2006

Declining Incidence of Catastrophic Cervical Spine Injuries in French Rugby

Reduced Versus Full Doses of Irradiation After 3 Cycles of Combined Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in Early Stage Hodgkin Lymphomas: Results of a Randomized Trial

Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas

Author reply

Author reply

Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation

Predictive and discriminating three‐risk‐group prognostic scoring system for staging Hodgkin lymphomas

Improving the Quality of Host Country Ethical Oversight of International Research: The Use of a Collaborative 'Pre-Review' Mechanism for a Study of Fexinidazole for Human African Trypanosomiasis

Intermediate stage Hodgkin lymphoma in partial remission after three or four courses of doxorubicin, bleomycin, vinblastine dacarbazine: no benefit of one course of intensive chemotherapy before irradiation

Fifteen‐year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high‐dose irradiation

Improving the Quality of Host Country Ethical Oversight of International Research: The Use of a Collaborative ‘Pre‐Review’ Mechanism for a Study of Fexinidazole for Human A frican Trypanosomiasis

Twenty‐year disease and treatment‐associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3‐month anthracycline‐based chemotherapy followed by extended high‐dose radiation

Fifteen-year secondary leukaemia risk observed in 762 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation

Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial

Binedaline Binding to Plasma Proteins and Red Blood Cells in Humans

Treatment of patients with advanced or bulky Hodgkin disease with a 12‐week doxorubicin, bleomycin, vinblastine, and dacarbazine‐like chemotherapy regimen followed by extended‐field, full‐dose radiotherapy

Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients

MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians

Modelling of the oxidation of Suspended Silicon Nanowires

Suchergebnisse filtern